文献
J-GLOBAL ID:202202290220789153
整理番号:22A0449750
細胞毒性CD56dimCD16+NK細胞の頻度低下はEBV陽性古典的ホジキンリンパ腫における抗体依存性脱顆粒障害をもたらす【JST・京大機械翻訳】
Reduced frequency of cytotoxic CD56dim CD16+ NK cells leads to impaired antibody-dependent degranulation in EBV-positive classical Hodgkin lymphoma
著者 (22件):
Panisova Elena
(Experimental Infectious Diseases and Cancer Research, University Children’s Hospital of Zurich, Zurich, Switzerland)
,
Panisova Elena
(Children’s Research Center, University Children’s Hospital of Zurich, Zurich, Switzerland)
,
Luenemann Anna
(Experimental Infectious Diseases and Cancer Research, University Children’s Hospital of Zurich, Zurich, Switzerland)
,
Luenemann Anna
(Children’s Research Center, University Children’s Hospital of Zurich, Zurich, Switzerland)
,
Luenemann Anna
(Department of Neurology With Institute of Translational Neurology, University of Muenster, Muenster, Germany)
,
Buergler Simone
(Experimental Infectious Diseases and Cancer Research, University Children’s Hospital of Zurich, Zurich, Switzerland)
,
Buergler Simone
(Children’s Research Center, University Children’s Hospital of Zurich, Zurich, Switzerland)
,
Kotur Monika
(Experimental Infectious Diseases and Cancer Research, University Children’s Hospital of Zurich, Zurich, Switzerland)
,
Kotur Monika
(Children’s Research Center, University Children’s Hospital of Zurich, Zurich, Switzerland)
,
Lazarovici Julien
(Department of Hematology, Gustave Roussy and Universite Paris Saclay, Villejuif, France)
,
Danu Alina
(Department of Hematology, Gustave Roussy and Universite Paris Saclay, Villejuif, France)
,
Kaulfuss Meike
(Cellular Immunotherapy, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland)
,
Mietz Juliane
(Cellular Immunotherapy, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland)
,
Chijioke Obinna
(Cellular Immunotherapy, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland)
,
Chijioke Obinna
(Institute of Pathology and Medical Genetics, University Hospital Basel, Basel, Switzerland)
,
Muenz Christian
(Viral Immunobiology, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland)
,
Busson Pierre
(CNRS UMR 9018, Gustave Roussy and Universite Paris Saclay, Villejuif, France)
,
Berger Christoph
(Experimental Infectious Diseases and Cancer Research, University Children’s Hospital of Zurich, Zurich, Switzerland)
,
Berger Christoph
(Children’s Research Center, University Children’s Hospital of Zurich, Zurich, Switzerland)
,
Ghez David
(Department of Hematology, Gustave Roussy and Universite Paris Saclay, Villejuif, France)
,
Azzi Tarik
(Experimental Infectious Diseases and Cancer Research, University Children’s Hospital of Zurich, Zurich, Switzerland)
,
Azzi Tarik
(Children’s Research Center, University Children’s Hospital of Zurich, Zurich, Switzerland)
資料名:
Cancer Immunology, Immunotherapy
(Cancer Immunology, Immunotherapy)
巻:
71
号:
1
ページ:
13-24
発行年:
2022年
JST資料番号:
W4135A
ISSN:
1432-0851
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)